LEAH FETZER: Open Payments
NPI 1780432112 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,475 in 56 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $385 · 2025 $1,475
Food & beverage: $1,475
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $375 |
| ABBVIE INC. | 10 | $211 |
| Neurocrine BioSciences, Inc. | 5 | $95 |
| Merck Sharp & Dohme LLC | 3 | $92 |
| PFIZER INC. | 4 | $90 |
| AstraZeneca Pharmaceuticals LP | 4 | $74 |
| Lilly USA, LLC | 3 | $66 |
| Exact Sciences Corporation | 3 | $60 |
| Aimmune Therapeutics, Inc. | 2 | $54 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $52 |
Products named: EVENITY, REPATHA, VRAYLAR, INGREZZA, QULIPTA, PREVNAR 20, MOUNJARO, GARDASIL 9.
Industry payments across MD — which companies pay providers there.
